Presentation TCT 2013 NSTEACS: Risk Stratification and Treatment Presenter: Dmitriy Feldman October 27, 2013 REGISTER for free or LOG IN to view this content ACS/AMI Presentation TCT 2013 Up Next Presentation TCT 2013 Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results Presenter: Michael Haude October 27, 2013 More slides + Presentation TCT 2013 Ultrasound, Radiation and Chemicals: What Constitutes a Disruptive Technology in Sympathetic Neuromodulation? Presenter: Peter Fitzgerald October 27, 2013 Presentation TCT 2013 When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention? Presenter: Michael Davidson October 28, 2013 We Recommend
Presentation TCT 2013 Update on the DREAMS Paclitaxel-eluting and Sirolimus-eluting Magnesium Scaffolds: Device Design, Elution Kinetics, Imaging and Extended Clinical Results Presenter: Michael Haude October 27, 2013
Presentation TCT 2013 Ultrasound, Radiation and Chemicals: What Constitutes a Disruptive Technology in Sympathetic Neuromodulation? Presenter: Peter Fitzgerald October 27, 2013
Presentation TCT 2013 When Does Pulmonary Hypertension, RV Dysfunction and/or Tricuspid Regurgitation Derail the Potential for Successful Mitral Valve Intervention? Presenter: Michael Davidson October 28, 2013